Key result
Proton magnetic resonance spectroscopy detected a significant increase in myocardial Lipid1 at week 6 after anthracycline injection (AUC 0.745), offering an earlier diagnosis of cardiotoxicity compared to conventional LVEF decline which occurred at week 8.
Why the study?
Anthracycline-induced cardiotoxicity limits anthracycline use due to severe adverse effects, and current diagnostic methods lack sensitivity for early detection.
Does 1H-MRS-detected myocardial lipid accumulation allow for earlier detection of anthracycline-induced cardiotoxicity compared to conventional LVEF monitoring in a rabbit model?
Does 1H-MRS-detected myocardial lipid accumulation allow for earlier detection of anthracycline-induced cardiotoxicity compared to conventional LVEF monitoring in a rabbit model?
1H-MRS can detect anthracycline-induced cardiotoxicity via myocardial lipid accumulation at 6 weeks, preceding conventional LVEF decline which occurs at 8 weeks.
BACKGROUND: Anthracycline-induced cardiotoxicity (AIC) poses significant challenges due to its severe adverse effects, limiting the use of anthracycline drugs (ATC). Early detection and intervention are pivotal, yet current diagnostic methods lack sensitivity. METHODS AND RESULTS: H-MRS). Results showed that Lipid1 increased significantly earlier at week 6 compared to the decreased left ventricular ejection fraction (LVEF) at week 8 (P<0.05). ROC analysis revealed that a Lipid1 cutoff value of 2.60 had the best diagnostic accuracy for AIC at week 6, with an area under the curve of 0.745, specificity of 0.71, and sensitivity of 0.80 (95% CI: 0.575-0.916). Lipid1 also demonstrated a moderately negative correlation with LVEF (r=-0.418, P<0.01). CONCLUSIONS: H-MRS-detected Lipid1 increased at week 6 after anthracycline injection, offering earlier diagnosis of AIC compared to conventional LVEF biomarkers.
No takes yet. Share an insight, caveat, or question.
Tu et al. (2025) studied Anthracycline-induced cardiotoxicity (n=20). Adriamycin vs. Baseline was evaluated on Diagnostic accuracy of Lipid1 cutoff value of 2.60 for anthracycline-induced cardiotoxicity at week 6 (AUC 0.745, 95% CI 0.575-0.916, p=<0.05). Proton magnetic resonance spectroscopy detected a significant increase in myocardial Lipid1 at week 6 after anthracycline injection (AUC 0.745), offering an earlier diagnosis of cardiotoxicity compared to conventional LVEF decline which occurred at week 8.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: